Gabather AB (publ) (GABA) - Cash Flow Conversion Efficiency

Latest as of September 2025: 1.858x

Based on the latest financial reports, Gabather AB (publ) (GABA) has a cash flow conversion efficiency ratio of 1.858x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-4.86 Million ≈ $-522.80K USD) by net assets (Skr-2.61 Million ≈ $-281.31K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Gabather AB (publ) - Cash Flow Conversion Efficiency Trend (2014–2024)

This chart illustrates how Gabather AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Read GABA liabilities breakdown for a breakdown of total debt and financial obligations.

Gabather AB (publ) Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Gabather AB (publ) ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Suumaya Industries Limited
NSE:SUULD
-0.016x
Cake Box Holdings PLC
LSE:CBOX
0.097x
INFINITII AI INC.
F:Y31
N/A
POLAREAN IMAG.LS-00037
F:8ZF
N/A
HTC Purenergy Inc.
V:HTC
0.006x
Inspecs Group plc
LSE:SPEC
0.071x
PDG Realty S.A. Empreendimentos e Participações
SA:PDGR3
0.000x
Trifast plc
LSE:TRI
0.049x

Annual Cash Flow Conversion Efficiency for Gabather AB (publ) (2014–2024)

The table below shows the annual cash flow conversion efficiency of Gabather AB (publ) from 2014 to 2024. For the full company profile with market capitalisation and key ratios, see Gabather AB (publ) market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 Skr-4.17 Million
≈ $-449.30K
Skr-3.33 Million
≈ $-358.15K
0.797x +103.33%
2023-12-31 Skr486.00K
≈ $52.30K
Skr-11.64 Million
≈ $-1.25 Million
-23.957x -758.22%
2022-12-31 Skr3.44 Million
≈ $369.98K
Skr-9.60 Million
≈ $-1.03 Million
-2.791x -89.90%
2021-12-31 Skr10.96 Million
≈ $1.18 Million
Skr-16.12 Million
≈ $-1.73 Million
-1.470x -209.74%
2020-12-31 Skr28.85 Million
≈ $3.10 Million
Skr-13.69 Million
≈ $-1.47 Million
-0.475x -51.21%
2019-12-31 Skr43.59 Million
≈ $4.69 Million
Skr-13.68 Million
≈ $-1.47 Million
-0.314x +75.16%
2018-12-31 Skr15.87 Million
≈ $1.71 Million
Skr-20.05 Million
≈ $-2.16 Million
-1.264x -497.58%
2017-12-31 Skr45.76 Million
≈ $4.92 Million
Skr-9.68 Million
≈ $-1.04 Million
-0.211x +0.97%
2016-12-31 Skr33.19 Million
≈ $3.57 Million
Skr-7.09 Million
≈ $-762.54K
-0.214x +50.12%
2015-12-31 Skr12.79 Million
≈ $1.38 Million
Skr-5.47 Million
≈ $-588.95K
-0.428x -141796.96%
2014-12-31 Skr8.63 Million
≈ $929.25K
Skr-2.60K
≈ $-280.32
0.000x --

About Gabather AB (publ)

ST:GABA Sweden Drug Manufacturers - Specialty & Generic
Market Cap
$1.04 Million
Skr9.64 Million SEK
Market Cap Rank
#30176 Global
#710 in Sweden
Share Price
Skr0.04
Change (1 day)
+13.97%
52-Week Range
Skr0.02 - Skr0.08
All Time High
Skr71.87
About

Gabather AB (publ), a pharmaceutical company, develops drug candidates for the treatment of central nervous system diseases. The company offers drugs primarily in the areas of anti-psychotics, anti-depressants and anxiolytics, and analgesics, as well as cognition-enhancing treatments, including Alzheimer's disease. It focuses on developing GT-002, a pro-cognitive drug candidate for the treatment … Read more